NexturnBioscience Financials
| 089140 Stock | KRW 3,395 100.00 3.03% |
NexturnBioscience |
Understanding current and past NexturnBioscience Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of NexturnBioscience's financial statements are interrelated, with each one affecting the others. For example, an increase in NexturnBioscience's assets may result in an increase in income on the income statement.
Please note, the presentation of NexturnBioscience's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, NexturnBioscience's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of NexturnBioscience's management manipulating its earnings.
NexturnBioscience Stock Summary
NexturnBioscience competes with ENERGYMACHINERY KOREA, Daishin Information, Nice Information, SCI Information, and Seoam Machinery. ,Ltd. develops and produces CNC automatic lathe machines in Korea and internationally. ,Ltd. was founded in 2000 and is based in Yongin, South Korea. NEXTURNBIO is traded on Korean Securities Dealers Automated Quotations in South Korea.| Instrument | Korea Stock View All |
| Exchange | KOSDAQ |
| ISIN | KR7089140008 |
| Business Address | 121 Beon-Gil 35, |
| Sector | Industrials |
| Industry | Machinery |
| Benchmark | Dow Jones Industrial |
| Website | www.nexturn.co.kr |
| Phone | 82 3 1288 2088 |
| Currency | KRW - South Korean Won |
You should never invest in NexturnBioscience without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of NexturnBioscience Stock, because this is throwing your money away. Analyzing the key information contained in NexturnBioscience's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
NexturnBioscience Key Financial Ratios
NexturnBioscience's financial ratios allow both analysts and investors to convert raw data from NexturnBioscience's financial statements into concise, actionable information that can be used to evaluate the performance of NexturnBioscience over time and compare it to other companies across industries.| Return On Equity | 2.07 | |||
| Return On Asset | 0.0793 | |||
| Target Price | 7500.0 | |||
| Number Of Employees | 56 | |||
| Beta | 1.05 |
NexturnBioscience Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining NexturnBioscience's current stock value. Our valuation model uses many indicators to compare NexturnBioscience value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NexturnBioscience competition to find correlations between indicators driving NexturnBioscience's intrinsic value. More Info.NexturnBioscience Co is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.04 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for NexturnBioscience Co is roughly 26.06 . Comparative valuation analysis is a catch-all model that can be used if you cannot value NexturnBioscience by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for NexturnBioscience's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.NexturnBioscience Systematic Risk
NexturnBioscience's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. NexturnBioscience volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on NexturnBioscience correlated with the market. If Beta is less than 0 NexturnBioscience generally moves in the opposite direction as compared to the market. If NexturnBioscience Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one NexturnBioscience is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of NexturnBioscience is generally in the same direction as the market. If Beta > 1 NexturnBioscience moves generally in the same direction as, but more than the movement of the benchmark.
NexturnBioscience November 28, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of NexturnBioscience help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of NexturnBioscience Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of NexturnBioscience Co based on widely used predictive technical indicators. In general, we focus on analyzing NexturnBioscience Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build NexturnBioscience's daily price indicators and compare them against related drivers.
| Downside Deviation | 5.09 | |||
| Information Ratio | 0.0307 | |||
| Maximum Drawdown | 44.3 | |||
| Value At Risk | (9.37) | |||
| Potential Upside | 8.97 |
Complementary Tools for NexturnBioscience Stock analysis
When running NexturnBioscience's price analysis, check to measure NexturnBioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NexturnBioscience is operating at the current time. Most of NexturnBioscience's value examination focuses on studying past and present price action to predict the probability of NexturnBioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NexturnBioscience's price. Additionally, you may evaluate how the addition of NexturnBioscience to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |